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Melilotus suaveolens Ledeb is a traditional medicinal plant for treating inflammation-related
disease. This explores the inner anti-inflammatory mechanism of n-butanol extract from
M. suaveolens Ledeb. Inflammatory cellular model was established by lipopolysaccharide
intervention on RAW264.7 cell line. Levels of secreted cytokines TNF-a, IL-1b, IL-6, NO and
IL-10 in supernatant, mRNA expression of TNF-a, COX-2, iNOS and HO-1, protein
expression of COX-2 and HO-1, activation of NF-kB and ingredients in the extract were
assayed by ELISA, real time quantitative PCR, western blot, immunocytochemical test and
HPLC fingerprint test, respectively. As a result, the extract could not only markedly reduce the
production of pro-inflammatory mediators to different extents by blocking NF-kB activation
but also promote the release of anti-inflammatory mediator HO-1 significantly. Each 1g extract
contained 0.023531mg coumarin and another two high polar ingredients, probably saponins.
It can be concluded that the extract has similar effects on antagonizing pro-inflammatory
mediators and cytokines like Dexamethasone, and has effects on promoting the production
of anti-inflammatory mediators.
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Introduction
Melilotus is a genus of plants including 20–25 species
that are widely distributed all over the world. The main
species used for medical purpose contain Melilotus albus
Desr, Melilotus officinalis Lam, Melilotus suaveolens
Ledeb, Melilotus dentatus (W.&K.) Pers, Melilotus indica
(L.) All, Melilotus italicus (L.) Lam, Melilotus volgicus
Poirr, Melilotus hirsutus Lipcky (L.) Lam, Melilotus
elegans Salzm, Melilotus salcatus Dest, Melilotus
neopolitanus Ten, etc. Melilotus suaveolens Ledeb is
distributed in the Far East region and used as herbal
medicine to treat inflammation and infection in throat
and alimentary system in China (1).
In literatures, there were a few reports on Melilotus.
It was documented that Melilotus is used to reduce
spasm (2); its coumarinic extract have effects on
lymphedema (3) and its polysaccharides have immuno-
correcting, anti-anemia and adaptogenic effects (4).
Although anti-inflammatory effect of M. officinalis was
reported (5), exploration on M. suaveolens Ledeb on how
to play an anti-inflammatory role at molecular level
remained limited.
As discovered at present, NF-kB is a family of seven
structurally related transcription factors that play a
central role in inflammation by controlling gene network
expression (6). Cyclooxygenease-2 (COX-2) is the key
enzyme regulating the production of prostaglandins,
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properly cited.the central mediators of inflammation. The expression
of COX-2 is induced by several extra cellular signals
including pro-inflammatory stimuli. COX-2 can be
affected directly at its enzymatic activity by nitric oxide
(NO) and inducible nitric oxide synthase (iNOS) (7).
NO is recognized as a mediator and regulator of inflam-
matory responses. It possesses cytotoxic properties that
are aimed against pathogenic microbes, but it can
also have damaging effects on host tissues. NO plays a
significant role in inflammation, where NO is produced
in high amounts by iNOS, and then reactive oxygen
species are synthesized by activated inflammatory cells
(8). Several pro-inflammatory gene products have been
identified that mediate a critical role in inflammation.
Among these gene products are tumor necrosis factor
(TNFa) and members of its superfamily, interleukin-1
beta (IL-1b), interleukin-6 (IL-6), etc. The expression of
all these genes is mainly regulated by the transcription
factor, nuclear factor-kappa B (NF-kB) (9). Therefore,
whether suppressed or not, those pro-inflammatory
cytokines and mediators are the key evaluation for
novel anti-inflammatory agents.
Interleukin-10 (IL-10) has attached much attention
because of its anti-inflammatory properties. Uniquely,
among hematopoietic cytokines, IL-10 is a pleiotropic
molecule that displays both immunostimulatory and
immunoregulatory activities (10). Heme oxygenase-1
(HO-1), involved in the heme degradation process, is an
important anti-inflammatory enzyme featured by its anti-
oxidant activity (11). Experimental models of various
diseases, including acute inflammation, have demonstrated
that the induction of HO-1 can prevent or mitigate the
symptoms associated with those ailments (12).
High performance liquid chromatography (HPLC) is a
method recommended by World Health Organization
(WHO) to assay herbal ingredients (13). Extraction by
n-butanol is one of the most common methods to obtain
organic substances that can not dissolve in water (14).
Basedonthosefindingsandmethods,weatfirstextracted
effective ingredients with n-butanol from M. suaveolens
Ledeb and identified the active components by HPLC
fingerprint. Then, we founded a classic inflammation
cellular model (15) with RAW 264.7 mouse macrophage
cell line stimulated by lipopolysaccharide (LPS). Subse-
quently, we chose the found inflammation cellular model to
explore the anti-inflammatory effect of n-butanol extract
from M. suaveolens Ledeb and clarified the inner anti-
inflammatory mechanisms of that medicinal plant.
Methods
Plant Materials
Melilotus suaveolens Ledeb was collected in August
2006 from Long County, Shanxi Province, China and
identified by Prof. Ke-Li Chen (School of Pharmacy,
Hubei College of Traditional Chinese Medicine) accord-
ing to Drug Standard of Ministry of Health of the People’s
Republic of China (Tibetan Medicine) (1). The plant
materials were stored in the plant specimen department,
school of pharmacy, Hubei College of Traditional
Chinese Medicine.
Preparation of n-Butanol extract from Melilotus
suaveolens Ledeb
Fifty grams air-dried aerial parts of M. suaveolens Ledeb
were powdered and extracted by 70% ethanol for three
times at 85 C( 3  500ml, 1.5h each time). The extract
solution was filtered and then combined and concen-
trated in vacuo. Subsequently, the concentrated solution
was diluted by deionized water to the concentration
of 1g extracted substances per 1ml water. Then the 5ml
concentrated liquid was accurately taken into a 100ml
separatory funnel by a 5ml Mohr measuring pipette and
was successively extracted with n-butanol to total dry
weight of n-butanol subfraction 2.425g. The dry material
of n-butanol subfraction was re-suspended with deionized
water to a concentration of 75mg/ml for HPLC analysis.
Then the solution was diluted by 1640 medium into
concentration of 10mgm l
 1,5mgm l
 1 and 1mgm l
 1 for
interfering in inflammation cellular model.
HPLC Fingerprint for Analyzing the Herb Extract
HPLC fingerprint was used to analyze the ingredients of
the herb extract (16). Balance (AB204-N, MAX 210g,
d = 0.1mg, produced by MERRLER TOLEDO Group.)
and UV-Detector (8450/HP, Agilent Science of Life and
Chemistry Company) were used. The HPLC system
consisted of a pump (model DIONEX P680 HPLC
Pump, ASI-100 to form a high pressure gradient)
with Automated Sample Injector facility, Chromeleon
management system and UV–VIS (UVD 170U) model
detector. The column was Kromasil C-18 (250 4.6mm,
10nm–5mm, Hanbon Science &.Technology Co., Ltd).
Chromatography conditions included: the gradient
elution was acetonitrile and 0.05% H3PO4 of 1.0ml
min
 1 flowing rate; 5ml capacity per injection was
used with UV detector at four kinds of wavelength of
220nm (for coumarin), 254 2nm, 275nm (for coumarin
and rutin) and 363nm (for hyperoside); the concentration
of reference of coumarin, rutin and hyperoside was
0.007648mg ml
 1, 0.2548mg ml
 1 and 0.2528mg ml
 1,
respectively; the column was placed in a column oven
set at 25 C. Then the petroleum ether subfraction
was filtered through a 0.45mm filter membrane
(Hanbon Science & Technology Co., Ltd) and stored
in the refrigerator before use. The multi-step gradient
elution was carried out with acetonitrile and 0.05%
H3PO4 solution. The procedure was as follows: 0–8min
98 n-butanol extract from Melilotus on anti-inflammation(5% acetonitrile, 95% H3PO4 solution), 8–25min (5–30%
acetonitrile, 95–70% H3PO4 solution), 25–35min
(30% acetonitrile, 70% H3PO4 solution), 35–60min
(30–70% acetonitrile, 70–30% H3PO4 solution),
60–70min(30%–5% acetonitrile, 70–95% H3PO4 solu-
tion), 70–80min(5% acetonitrile, 95% H3PO4 solution).
Chemicals and Reagents
RPMI1640 was from Gibico (Grand Island, NY, USA).
LPS (Escherichia coli O111:B4) and methyl thiazolyl
tetrazolium (MTT) were obtained from Sigma (St Louis,
MO, USA). Affinity-purified goat anti-mouse HO-1 anti-
body was obtained from R&D Systems (Minneapolis,
MN, USA). Affinity-purified goat anti-mouse COX-2
antibody and rabbit anti-mouse NF-kB p65 IgG anti-
body were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Mouse TNF-a, IL-1b and IL-6
ELISA kits were purchased from Quantikine, R&D
Systems (Minneapolis, MN, USA). Griess reagent
nitric oxide assay kit was from Beyotime Biotech
(Jiangsu, P. R. China). Mouse IL-10 ELISA kit was
obtained from Bender Medsystem (Vienna, Austria).
Trizol was purchased from Gibico (Grand Island, NY,
USA). M-MLV Reverse Transcriptase was afforded from
Promega (Madison, WI, USA). SYBR GreenI was taken
from Biotium (Hayward, CA, USA). The Oligo(dT18)
and primers were synthesized by Shanghai Invitrogen
(Shanghai, China). The dNTP was obtained from
Promega (Madison, WI, USA).
Cell Culture
Murine macrophage cell line RAW264.7 was obtained
from China Center for Typical Culture Collection
(CCTCC) (Wuhan, China). The cell was maintained
in RPMI1640 medium supplemented with 100 U ml
 1 of
penicillin, 100mgm l
 1 of streptomycin and 10% fetal
bovine serum and was cultured at 37 C and 5% CO2
in humidified air.
Cellular Model Establishment and Intervention
Twenty four hours prior to LPS treatment, the cells were
inoculated into 6, 24 or 96 micro-well plates. Twenty four
hours later, when the cells were observed for adherence
at the bottom of well, cell supernatants were disposed
and 10ng ml
 1 LPS with prepared exact solution were
added into the well. The stimulation and intervention
lasted for different hours and the supernatants and cells
were harvested for ELISA, real-time PCR, western-blot
and immunocytochemical test.
Control Establishment
Dexamethasone, which is known as a classic gluco-
corticosteroid drug widely used in clinical practice,
was chosen as positive control with concentration
of 0.5mgm l
 1. Astragalus polysaccharides (APS) is an
immunomodulator to reinforce immune response on
TNF-a, IL-1b and IL-6 (17). According to the literature
(17), APS with concentration of 100mgm l
 1 was selected
as negative control for monitoring the procedure. Cells
stimulated by LPS without any intervention were
observed as blank control. Cells incubated by 1640
medium were as normal control.
MTT Assay for Measuring Cell Proliferation
Based on the instruction from the American Type
Culture Collection (ATCC), cytotoxic effect of the
extract was evaluated by MTT assay. At 4h prior to
culture termination, 20ml MTT solution (5mg ml
 1 in
a phosphate-buffered saline, pH 7.4) was added. When
cell culture was terminated, 150ml dimethyl sulfoxide
was added into each well for solubilization. The optical
density at 490nm was measured by a Spectramax 250
microplate reader.
Cytopathic Effect (CPE) Test for Cell Morphous
Observation
After cell model interfered with the extract for 24h, CPE
test was performed for observing cell morphous.
Detection of TNF-a, IL-1b and IL-6 in Supernatant
Inhibitory effects of 10mgm l
 1,5mgm l
 1 and 1mgm l
 1
extract on the cytokine TNF-a, IL-1b and IL-6 produc-
tion from LPS-treated RAW264.7 cells were determined
by sandwich ELISA. After stimulation and intervention
on RAW264.7 cells for 24h, supernatant was harvested
and assayed for TNF-a, IL-1b and IL-6 by respective
ELISA kits. The procedure obeyed to instructions from
related kits. Results of three independent experiments
were used for statistical analysis.
Analysis of Nitric Oxide
Levels of the NO derivative nitrite were determined with
the Griess reaction. The nitrite detection kit was used
according to instructions provided by the manufacturer.
The samples were assayed in triplicate, and a standard
curve using NaNO2 was generated for each experiment
for quantification. Briefly, 100ml of medium or standard
NaNO2 was mixed with 100ml of Griess reagent in a
96-well plate. After 15min, optical density was read in
a microplate reader at 540nm.
Real-time PCR for Detecting mRNA of TNF-a, COX-2,
iNOS and HO-1
The total RNA from stimulated and interfered cell
model was prepared by adding TRIzol Reagent according
eCAM 2010;7(1) 99to manufacturer’s protocol. The RNA on TNF-a, indu-
cible iNOS and COX-2 was extracted at 4h after
stimulation and intervention and the RNA on HO-1
was obtained at 18h after stimulation and intervention.
Quantitative PCR was performed in ABI-7700 Sequence
Detector (Applied Biosystems, Foster City, CA, USA).
The reverse transcription was performed with M-MLV
Reverse Transcriptase. The reverse transcription reac-
tion system included: 5.5mlH 2O, 1.0ml Oligo(dT18)
(50mgm l
 1), total RNA 6.0ml, 70 C 5min to ice for
unfolding secondary structure of mRNA; 0.5ml RNasin
(40U ml
 1), 4.0ml5 buffer, 2.0ml dNTP (10mM), 1.0ml
RTase (200 U ml
 1), 42 C 60min to 95 C 5min to 4 C
at the end. Real time PCR reaction was performed with
SYBR GreenI fluorochrome. The standard curve of each
sample was obtained and cycle threshold (Ct) value was
calculated. Each 50ml PCR system contained 1/50 of the
original cDNA synthesis reaction, 7ml (25mM) MgCl2,
0.8ml (20 pmol ml
 1) of each primer, 1ml (10mM) dNTP,
1ml SYBR GreenI, 0.5ml( 5 Uml
 1) Taq and 5ml
10 Buffer. Fifty cycles of amplification were performed:
after 94 C 3min, reaction cycle with 94 C, 30min,
to 57 C, 30s, then to 72 C, 30s was carried out for 50
times. The fluorescence signal was detected at the end
of each cycle. Melting curve analysis was used to
confirm the specificity of the products. The 2
 CT
method was performed to analyze the results (18). The
primer was as below:
Mus-COX-2:
Forward: 50-GAAGTCTTTGGTCTGGTGCCTG-30,
Reverse: 50-GTCTGCTGGTTTGGAATAGTTGC-30;
Mus-iNos:
Forward: 50-GGAGCGAGTTGTGGATTGTC-30,
Reverse: 50-GTGAGGGCTTGGCTGAGTGAG-30;
Mus-TNF-a:
Forward: 50-GTGGAACTGGCAGAAGAGGC-30,
Reverse: 50-AGACAGAAGAGCGTGGTGGC-30;
Mus-HO-1:
Forward: 50-CACAGATGGCGTCACTTCGTC-30,
Reverse: 50-GTGAGGACCCACTGGAGGAG-30.
Mus-b-actin:
Forward: 50-GCTACAGCTTCACCACCACAG-30,
Reverse: 50-GGTCTTTACGGATGTCAACGTC-30.
Western Blot Analysis of COX-2 and HO-1
The treated cells were harvested and incubated on ice for
15min in a lysis buffer of 50mM Tris–HCl (pH 7.4),
150mM NaCl, 100mg ml
 1 phenyl methylsulfonyl
fluoride, 1mg ml
 1 aprotinin and 1% Triton X-100.
Cell debris was removed by centrifugation at
10000r.p.m. and 4 C for 10min. The protein concentra-
tion of each cell lysate was determined with a Bio-Rad
(Hercules, CA, USA) protein assay kit. To each tube,
an equivalent volume of 2 sodium dodecyl sulfate
(SDS) loading buffer (100mM Tris–HCl, pH 6.8, 4%
SDS, 20% glycerine, 10% b-mercaptoethanol and
0.2% bromophenol blue) was added and mixed again.
The mixtures were then denatured at 95 C for 10min,
and about 10mg of the protein mixture was loaded and
separated in each well on 10% SDS-polyacrylamide
electrophoresis gels. After separation for about 80min,
the proteins were transblotted onto nitrocellulose
membranes (Bio-Rad), and the membranes were
saturated and blocked with 5% fat-free milk at 37 C
for 1h. Membranes were probed with goat polyclonal
anti-COX-2, anti-HO-1 (1:6000) and then with horse-
radish peroxidase-conjugated secondary immunoglobulin
G (IgG, Kangcheng, Shanghai, P.R. China). The mem-
branes were then treated with an enhanced chemilumi-
nescence reagent (Amersham, Piscataway, NJ, USA),
and the signals were detected by exposure of the
membranes to X-ray films (Kodak, Rochester, NY,
USA). The relative signal intensity was quantified
by densitometry with Gel pro3.0 image software
(Media Cybernetics, Silverspring, MD, USA) for an
IBM-compatible personal computer. All experiments
were performed three times independently.
Immunocytochemistry Assay for NF-kB
SP immunocytochemical assay was employed to detect
expression of the nuclear translocation of NF-kB.
Coverslips were soaked in polylysine for whole night.
After cell crawling to the coverslips and subsequent LPS
stimulation and extract intervention, the cells were fixed
by acetone. Then the slides with cells were soaked in 3%
H2O2–methanol solution for 20min, in order to block
endogenous peroxydase. Next, 1% Triton X-100 was
added at 37 C for 5min, followed by PBS washing.
After incubated with normal goat serum at room
temperature for 20min, rabbit anti-mouse NF-kB p65
IgG antibody was drop wise and the slides were stored at
4 C for whole night. Next day following PBS washing,
biotin-conjugated goat anti-rabbit IgG was added drop
wise and the incubation lasted 30min at 37 C. Then with
PBS washing again, streptavidin-HRP was added and
incubated with cells for 30min at 37 C. Subsequently,
with PBS washing for 5min, three times, DAB coloration
was performed. Following normal dehydration, lucidifi-
cation and mounting, the slides were pictured.
Statistical Analysis
Data were presented as means SD of three separate
experiments. Comparisons between multiple groups
were performed with one-way ANOVA test. Statistical
significance was considered significant when P<0.05.
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HPLC Fingerprint of n-butanol Extract from
Melilotus suaveolens Ledeb
As coumarin and hyperoside had been reported
in Melilotus and coumarin was isolated from
M. suaveolens Ledeb in our chemistry study, coumarin
and hyperoside were taken as standard substance to
perform fingerprint assay. Rutin is an anti-inflammatory
flavone derivative commonly existing in many medical
plants (19), so we also select rutin as standard substance
in ingredient analysis test. As shown in Fig. 1, according
to the peaks of HPLC fingerprint, it could be inferred
that there was no rutin and hyperoside in the extract.
There was 0.023531mg coumarin in each 1g extract.
The coincidence of peaks of coumarin and ingredient
in the extract at 275nm showed that the coumarin was
one of the main components. At 275nm, there were
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Figure 1. HPLC fingerprint of the n-butanol extract from M. suaveolens Ledeb: line 1 represents n-butanol solution; line 2 represents standard
substances of coumarin; line 3 represents rutin and line 4 represents rutin and hyperoside.
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which could infer that there were another two substances
in the extract. The polarity of the two substances was
higher than that of rutin, hyperoside and coumarin and
according to the polar region in HPLC, they might
be saponins.
In vitro Cytotoxicity of n-Butanol Extract from
Melilotus suaveolens Ledeb
Based on MTT assay, it showed that pre-treatment on
unstimulated RAW264.7 cells with prepared solution
of n-butanol extract from Melilotus suaveolens Ledeb
(concentration mentioned earlier) for 24h did not signifi-
cantly affect cell viability (data not shown). CPE test
presented the same result (Fig. 2).
Inflammatory Model Establishment
and Procedure Monitoring
As shown from figures on pro-inflammatory cytokines
and mediators, the levels of those factors of cells
stimulated by LPS were significantly higher than those
of normal cells (P<0.01), which implied the successful
establishment of model of inflammation. Meanwhile, the
levels of those mediators of cells by Dexamethasone
intervention was significantly lower than those of single
LPS stimulation (P<0.01). The levels of TNF-a, IL-1b
and IL-6 of cells by APS intervention were significantly
higher than those of single LPS stimulation (P<0.05 or
0.01). The effects of Dexamethasone and APS interven-
tion demonstrated the experimental procedure was
proper.
n-Butanol Extract from Melilotus Suaveolens Ledeb
on Pro-inflammatory Cytokines Release
As shown in Fig. 3A–C, after LPS stimulation with the
extract intervention for 24h, secretion of TNF-a, IL-1b
and IL-6 were significantly decreased than that in single
LPS stimulation (P<0.01). Furthermore, it could be
observed that the more the dosage of the extract
increased, the better the effects of antagonizing pro-
inflammatory cytokines would be (P<0.01at 10 times
concentration).
Protein of COX-2 expression
The extract displayed strikingly decreased level of COX-2
protein as shown in Fig. 4 (P<0.01). It was suggested that
n-butanol extract from M. suaveolens Ledeb could control
pro-inflammatory mediator production at protein levels.
Gene Expression of Pro-inflammatory Mediators
The extract displayed strong inhibition effect on
expression of TNF-a and COX-2 mRNA as shown in
Fig. 5A–B (P<0.01 or 0.05). Furthermore, the more the
dosage of the extract increased, the better the effects of
antagonizing pro-inflammatory gene expression would
be (P<0.01 at 10 times concentration). It suggested
that n-butanol extract from M. suaveolens Ledeb might
control pro-inflammatory cytokine production at gene
levels.
NO Release and iNOS Expression
As shown in Fig. 3D, after LPS stimulation with
n-butanol extract from M. suaveolens Ledeb intervention,
secretion of NO was significantly decreased than that
by single LPS stimulation (P<0.01). Furthermore,
the more the dosage of the extract increased, the better
the effects of antagonizing NO releasing would be
(P<0.01at 10 times concentration). Also, as shown in
Fig. 5C, the effect of n-butanol extract from
M. suaveolens Ledeb on mRNA expression of iNOS
was coinciding with that of NO (P<0.01).
AB
Figure 2. (A) The cells before intervention of n-butanol extract from M. suaveolens Ledeb;( B) the cells after intervention of 1mgm l
 1 n-butanol
extract from M. suaveolens Ledeb for 24h.
102 n-butanol extract from Melilotus on anti-inflammationIL-10 Release
As shown in Fig. 6A, the level of IL-10 decreased the
most under APS condition, which illustrated the effect
of APS on reinforcing cellular immunity and inhibiting
humoral immunity. Increase of IL-10 on single LPS
stimulation displayed the regulatory action on cells after
inflammatory reaction. The levels of IL-10 interfered
by the extracts were similar to that by Dexamethasone.
HO-1 mRNA and Protein Expression
As shown in Fig. 6B and Fig. 7, the levels of HO-1
mRNA and protein of single LPS stimulated cells and
Dexamethasone interfered cells were not different to the
levels of normal incubated cell. The levels of HO-1
mRNA and protein by the extracts and APS intervention
were significantly higher than those by single LPS
stimulation and normal incubation (P<0.01), which
suggested that n-butanol extract from M. suaveolens
Ledeb could promote regression of inflammation.
Furthermore, the higher concentration of the extract,
the stronger expression of HO-1 mRNA and protein
(P<0.01at 10 times concentration), which showed dose-
dependent relation between effect of promoting anti-
inflammatory mediators and concentration of n-butanol
extract from M. suaveolens Ledeb.
Inhibition of NF-kB
The results of immunocytochemistry in Fig. 8 showed
NF-kB activation was significantly blocked by n-butanol
extract from M. suaveolens Ledeb (P<0.01). It could be
inferred that suppression of IL-1b, TNF-a, iNOS
and COX-2 expression by n-butanol extract from
M. suaveolens Ledeb might be due to the blocking of
NF-kB activation.
Discussion
Over the past, it has been confirmed that Melilotus
extract has anti-inflammatory properties similar to those
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Figure 3. Effects of n-butanol extract from M. suaveolens Ledeb on production of pro-inflammatory cytokines and mediators. RAW264.7 cells were
treated with LPS (10ng/ml) in the presence of different concentrations of n-butanol extract from M. suaveolens Ledeb for 24h. Cytokine or mediator
levels were measured by ELISA or Griess method. Data were shown as mean SD (n=3). *P<0.05 compared to LPS alone; **P<0.01 compared
to LPS alone; ***P<0.01 compared to normal cell. (A) Effect on TNF-a production; (B) effect on IL-1b production; (C) effect on IL-6 production
and (D) effect on NO production.
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Figure 4. Effects of n-butanol extract from M. suaveolens Ledeb on
COX-2 protein expression assayed by western blot analysis. RAW264.7
cells were treated with LPS (10ng ml
 1) in the presence of different
concentrations of n-butanol extract from M. suaveolens Ledeb for 24h.
eCAM 2010;7(1) 103of hydrocortisone sodium hemisuccinate and coumarin,
and in bone marrow acute phase response, Melilotus has
an inhibitory action that is lower than that of hydro-
cortisone sodium hemisuccinate and similar to coumarin
(5). However, Melilotus on anti-inflammation has not
been well explored in detail so far, and anti-inflammatory
effect on n-butanol extract from M. suaveolens Ledeb was
not investigated in literature.
As many active ingredients in a medicinal plant are
organic, and the contents of M. officinalis were pre-
liminarily studied in the past, we chose n-butanol
extraction to simplify the components of M. suaveolens
Ledeb. HPLC fingerprint of the herbal extract showed
that the main content of n-butanol extract from
M. suaveolens Ledeb was coumarin. Although it was
reported that hyperoside was also an effective ingredient
of Melilotus on anti-inflammation, there was no hypero-
side detected in the n-butanol extract from M. suaveolens
Ledeb. In addition, another two ingredients with higher
polarity than that of rutin, hyperoside and coumarin
were discovered. It is our next investigation, whether and
how the ingredients play an interaction role with
coumarin for anti-inflammation in the extract.
TNF-a, IL-1b, IL-6 are classic pro-inflammatory
cytokines, which rise in most inflammatory stimulations.
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Figure 5. Effects of n-butanol extract from M. suaveolens Ledeb on
mRNA expression of pro-inflammatory cytokines and mediators.
RAW264.7 cells were treated with LPS (10ng ml
 1) in the presence
of different concentrations of n-butanol extract from M. suaveolens
Ledeb for 4h. The mRNA levels were measured by real-time
quantitative PCR. Data were shown as mean SD (n=3). *P<0.05
compared to LPS alone; **P<0.01 compared to LPS alone;
***P<0.01 compared to normal cell. (A) Effect on TNF-a mRNA
expression; (B) effect on COX-2 mRNA expression and (C) effect on
iNOS mRNA expression.
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Figure 6. Effects of n-butanol extract from M. suaveolens Ledeb on
expression of anti-inflammatory cytokines and mediators. RAW264.7
cells were treated with LPS (10ng ml
 1) in the presence of different
concentrations of n-butanol extract from M. suaveolens Ledeb for 24h
(IL-10) or 18h (HO-1 mRNA). The IL-10 levels were measured by
ELISA and HO-1 mRNA levels were measured by real-time quantita-
tive PCR. Data were shown as mean SD (n=3). *P<0.05 compared
to LPS alone; **P<0.01 compared to LPS alone; ***P<0.01
compared to normal cell. (A) Effect on IL-10 production and
(B) effect on HO-1 mRNA expression.
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Figure 7. Effects of n-butanol extract from M. suaveolens Ledeb on
HO-1 protein expression assayed by western blot analysis. RAW264.7
cells were treated with LPS (10ng ml
 1) in the presence of different
concentrations of n-butanol extract from M. suaveolens Ledeb for 24h.
104 n-butanol extract from Melilotus on anti-inflammationIn our research, we examined the effect of n-butanol
extract from M. suaveolens Ledeb on those three
cytokines and the inhibiting effect inferred the anti-
inflammatory properties of that medicinal plant.
Subsequently, we detected the intra-cellular inflamma-
tory regulatory factors, in order to make clear the anti-
inflammatory mechanism of n-butanol extract from
M. suaveolens Ledeb. As COX-2 is a key protein to
regulate evoke of inflammation, we examined protein
expression of COX-2. Then, we further assayed the
mRNA expression of COX-2 and the most important
cytokine, TNF-a, to ascertain the influence of the extract
at gene level.
NO is a multi-function mediator to deliver signals in
many reactions. Inflammation is one of the most occa-
sions for NO to play a central role. It has been affirmed
that including COX-2, many pro-inflammatory cytokines
and proteins are regulated or influenced by NO and on
inflammatory condition both NO and its enzyme, iNOS
evaluate. Thereby, we chose NO and iNOS as an index
to measure the anti-inflammatory effect.
NF-kB is a central factor to control nuclear transcrip-
tional signals by which many cellular functions, including
inflammation, are activated. After detecting the main
inflammatory cytokines and mediators, we explored the
conditions of nuclear transcription by assaying whether
NF-kB was activated.
In this research, the pathway of activating inflamma-
tion was examined carefully, and it could be proved
that n-butanol extract from M. suaveolens Ledeb has
suppressive effects on inflammation. Furthermore, we
compared the anti-inflammatory effect between n-butanol
extract from M. suaveolens Ledeb and Dexamethasone.
It showed that n-butanol extract from M. suaveolens
Ledeb has a similar efficacy on antagonizing the produc-
ing, releasing and activating of pro-inflammatory media-
tors, cytokines and NF-kB.
Apart from pro-inflammatory factors, we also detected
effect of n-butanol extract from M. suaveolens
Ledeb on anti-inflammatory factors. IL-10 is a typical
anti-inflammatory cytokine after inflammatory stimula-
tion that is capable of inhibiting synthesis of pro-
inflammatory cytokines like IF-g, TNF-a and GM-CSF
made by cells such as macrophages and the Type 1T
helper cells. HO-1 is an inducible enzyme in response
to suppress stress such as inflammation, oxidative stress,
hypoxia, etc. Both the factors are considered as impor-
tant roles on anti-inflammation. As reported, Dexa-
methasone can inhibit the release of IL-10at high dosage
(20), while n-butanol extract from M. suaveolens Ledeb
had a similar effect on IL-10 in our research. However,
n-butanol extract from M. suaveolens Ledeb had an
ability on inducing production of HO-1 but Dexamethe-
sone not, which showed the difference between the
extract and Dexamethasone. This feature might be a
possible application of M. suaveolens Ledeb in clinical
practice in the future.
Although M. suaveolens Ledeb has been reported for
its anti-inflammation properties in clinical practice,
the inner molecular biological mechanisms have not
been well investigated. The effect of n-butanol extract
from M. suaveolens Ledeb on pro-inflammatory cytokines
and mediators, on blocking translocation of NF-kB,
on anti-inflammatory mediators and on comparison to
Dexamethesone are first explored. Additionally, two high
polar ingredients in M. suaveolens Ledeb are discovered
in the extract. Based on our past study on herbal research
(21,22) and recent advance on herbal medicine (23,24),
the next exploration is on analyzing more activities of the
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Figure 8. Effects of n-butanol extract from M. suaveolens Ledeb on
NF-kB translocation. RAW264.7 cells were treated with LPS
(10ng ml
 1) in the presence of different concentrations of the extract
for 2h. Cell nucleus stained to brown presented NF-kB activation and
cytoplasm stained to brown presented NF-kB inactivation. (A) Extract
plus LPS of 10mgm l
 1;( B)5 mgm l
 1 extract plus LPS; (C): 1mgm l
 1
extract plus LPS; (D) Dexamethasone plus LPS; (E) APS plus LPS;
(F) simple LPS and (G) normal medium.
eCAM 2010;7(1) 105ingredients in M. suaveolens Ledeb and further applica-
tion of this medicinal plant product on certain
inflammation-related disease, such as encephalitis, hepa-
topathy and systemic inflammatory response syndrome.
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